Literature DB >> 15666172

Antipsychotic prescribing pattern among Italian general practitioners: a population-based study during the years 1999-2002.

Gianluca Trifirò1, Edoardo Spina, Ovidio Brignoli, Emiliano Sessa, Achille P Caputi, Giampiero Mazzaglia.   

Abstract

OBJECTIVES: To assess the antipsychotic use and the prevalence/incidence of antipsychotic drug users in Italy during the years 1999-2002. To estimate the persistence with antipsychotic medications, and to measure their off-label use.
METHODS: We selected 465,061 individuals registered by June 2002 in the lists of 320 general practitioners, homogeneously distributed throughout Italy, from the Health Search Database. We measured the antipsychotic drug consumption, calculated as defined daily dose (DDD) per 1000 inhabitants per day. We also calculated the number of individuals receiving at least one antipsychotic prescription, to estimate the annual prevalence and incidence of antipsychotic users. Among incident users, we evaluated the percentage of patients adherent to drug label indications and the average duration of treatment, estimated as medical possession ratio (MPR).
RESULTS: Atypical antipsychotic use has continuously increased from 1999 to 2002. Women, older people and patients affected by psychotic disorders other than schizophrenia were seen to be more likely to receive antipsychotic prescriptions. Persistence with atypical drug treatment (MPR=0.213 in 2002) appeared longer than that of typical drugs (0.169). The percentage of patients adherent to drug label indications was significantly higher among typical antipsychotic users (P<0.001). The most common off-label use for atypical drug was senile dementia.
CONCLUSION: Atypical drug use has been continuously expanding over the years 1999-2002, particularly in older people with dementia. The rapidly increasing use of this new class of antipsychotics highlights the need for a better evaluation regarding their safety profile and a better definition of their role in psychiatric treatments.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15666172     DOI: 10.1007/s00228-004-0868-3

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  CSM warning on atypical psychotics and stroke may be detrimental for dementia.

Authors:  Donald Mowat; Douglas Fowlie; Tom MacEwan
Journal:  BMJ       Date:  2004-05-22

2.  How much are atypical antipsychotic agents being used, and do they reach the populations who need them? A Canadian experience.

Authors:  Carolyn S Dewa; Gary Remington; Nathan Herrmann; Joan Fearnley; Paula Goering
Journal:  Clin Ther       Date:  2002-09       Impact factor: 3.393

3.  Effects of an automated electronic reminder in changing the antiplatelet drug-prescribing behavior among Italian general practitioners in diabetic patients: an intervention trial.

Authors:  Alessandro Filippi; Andrea Sabatini; Letizia Badioli; Fabio Samani; Giampiero Mazzaglia; Alberico Catapano; Claudio Cricelli
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

4.  Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study.

Authors:  James A Kaye; Brian D Bradbury; Hershel Jick
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

5.  Variations in prescribing atypical antipsychotic drugs in primary care: cross-sectional study.

Authors:  Darren M Ashcroft; Martin Frischer; Joanne Lockett; Stephen R Chapman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2002-06       Impact factor: 2.890

6.  Prescribing second-generation antipsychotics and the evolving standard of care in Italy.

Authors:  C Barbui; A Danese; G Guaiana; L Mapelli; L Miele; E Monzani; M Percudani
Journal:  Pharmacopsychiatry       Date:  2002-11       Impact factor: 5.788

7.  Analysis of healthcare utilization patterns and adherence in patients receiving typical and atypical antipsychotic medications.

Authors:  Ibrahim S Al-Zakwani; John J Barron; Michael F Bullano; Steve Arcona; Christopher J Drury; Tara R Cockerham
Journal:  Curr Med Res Opin       Date:  2003       Impact factor: 2.580

8.  Conventional, atypical, and combination antipsychotic prescriptions: a 2-year comparison.

Authors:  Raymond P Tempier; Nicole H Pawliuk
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

9.  Secondary prevention of stroke in Italy: a cross-sectional survey in family practice.

Authors:  Alessandro Filippi; Angelo Antonio Bignamini; Emiliano Sessa; Fabio Samani; Giampiero Mazzaglia
Journal:  Stroke       Date:  2003-03-13       Impact factor: 7.914

10.  Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns.

Authors:  Rogelio Apiquian; Ana Fresán; Camilo de la Fuente-Sandoval; Rosa-Elena Ulloa; Humberto Nicolini
Journal:  BMC Psychiatry       Date:  2004-04-27       Impact factor: 3.630

View more
  13 in total

1.  Increased use of second generation antipsychotic drugs in primary care: potential relevance for hospitalizations in schizophrenia patients.

Authors:  Macarena C Cáceres; Eva María Peñas-Lledó; Alfredo de la Rubia; Adrián Llerena
Journal:  Eur J Clin Pharmacol       Date:  2007-10-19       Impact factor: 2.953

2.  Antipsychotic treatment patterns and hospitalizations among adults with schizophrenia.

Authors:  Susan dosReis; Elizabeth Johnson; Donald Steinwachs; Charles Rohde; Elizabeth A Skinner; Maureen Fahey; Anthony F Lehman
Journal:  Schizophr Res       Date:  2008-02-05       Impact factor: 4.939

Review 3.  Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies.

Authors:  Gianluca Trifiró; Janet Sultana; Edoardo Spina
Journal:  Drug Saf       Date:  2014-07       Impact factor: 5.606

4.  Correlates and psychiatric disorders associated with psychotropic drug use in Taiwan.

Authors:  I-Chia Chien; Shin-Huey Bih; Ching-Heng Lin; Yiing-Jenq Chou; Wen-Guang Lee; Cheng-Hua Lee; Pesus Chou
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-11-20       Impact factor: 4.328

5.  Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara.

Authors:  Giacomo Chiabrando; Stefano Bianchi; Elisabetta Poluzzi; Nicola Montanaro; Paola Scanavacca
Journal:  Eur J Clin Pharmacol       Date:  2010-05-13       Impact factor: 2.953

Review 6.  Use of atypical antipsychotics in the elderly: a clinical review.

Authors:  Pietro Gareri; Cristina Segura-García; Valeria Graziella Laura Manfredi; Antonella Bruni; Paola Ciambrone; Gregorio Cerminara; Giovambattista De Sarro; Pasquale De Fazio
Journal:  Clin Interv Aging       Date:  2014-08-16       Impact factor: 4.458

7.  Prescribing pattern of antipsychotic drugs during the years 1996-2010: a population-based database study in Europe with a focus on torsadogenic drugs.

Authors:  Alessandro Oteri; Giampiero Mazzaglia; Serena Pecchioli; Mariam Molokhia; Sinna Pilgaard Ulrichsen; Lars Pedersen; Elisabetta Poluzzi; Fabrizio De Ponti; Edeltraut Garbe; Tania Schink; Ron Herings; Irene D Bezemer; Miriam C J M Sturkenboom; Gianluca Trifirò
Journal:  Br J Clin Pharmacol       Date:  2016-05-18       Impact factor: 4.335

8.  Antipsychotic drug use and community-acquired pneumonia.

Authors:  Gianluca Trifirò
Journal:  Curr Infect Dis Rep       Date:  2011-06       Impact factor: 3.725

9.  Main clinical features in patients at their first psychiatric admission to Italian acute hospital psychiatric wards. The PERSEO study.

Authors:  Andrea Ballerini; Roberto M Boccalon; Giancarlo Boncompagni; Massimo Casacchia; Francesco Margari; Lina Minervini; Roberto Righi; Federico Russo; Andrea Salteri; Sonia Frediani; Andrea Rossi; Marco Scatigna
Journal:  BMC Psychiatry       Date:  2007-01-19       Impact factor: 3.630

10.  Clinical features and therapeutic management of patients admitted to Italian acute hospital psychiatric units: the PERSEO (psychiatric emergency study and epidemiology) survey.

Authors:  Andrea Ballerini; Roberto M Boccalon; Giancarlo Boncompagni; Massimo Casacchia; Francesco Margari; Lina Minervini; Roberto Righi; Federico Russo; Andrea Salteri; Sonia Frediani; Andrea Rossi; Marco Scatigna
Journal:  Ann Gen Psychiatry       Date:  2007-11-05       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.